Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue:    
Products, services, other $ 525,998 $ 454,350
Grant revenue 25,359 56,128
Total revenue 551,357 510,478
Costs and expenses:    
Cost of products and services 235,997 221,699
Research and development 263,456 335,270
Selling and marketing 213,009 191,236
General and administrative 837,998 808,218
Total operating costs and expenses 1,550,460 1,556,423
Operating loss (999,103) (1,045,945)
Other (expense) income:    
Interest expense, net (1,526,632) (835,144)
Other expense (959) (912)
Impairment loss on investment (6,069)
Change in fair value of derivative liabilities (3,061,752) (4,068,390)
Total other (expense) income (4,595,412) (4,904,446)
Net loss $ (5,594,515) $ (5,950,391)
Net loss per common share - basic and diluted $ (0.18) $ (0.26)
Weighted average common stock shares outstanding – basic and diluted 31,223,061 23,198,360